Pharmacia & Upjohn sues FDA for denying Rogaine exclusivity.
This article was originally published in The Tan Sheet
Executive Summary
PHARMACIA & UPJOHN SEEKS REVERSAL OF ROGAINE EXCLUSIVITY DECISION in a suit brought against FDA on April 12. Filed in U.S. District Court for the Western District of Michigan, the lawsuit asks the court to "reverse FDA's adverse ruling on Rogaine market exclusivity...and order FDA to defer approval of competing nonprescription products containing minoxidil."